Literature DB >> 28344787

Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia.

Giovanni Sarnelli1, Michela Grosso2, Ilaria Palumbo1, Marcella Pesce1, Alessandra D'Alessandro1, Giovanni Zaninotto3, Vito Annese4, Raffaella Petruzzelli2, Paola Izzo2, Rossana Sepulveres2, Dario Bruzzese5, Giuseppe Esposito6, Rosario Cuomo1.   

Abstract

BACKGROUND: Polymorphisms of genes involved in the regulation of the immune response are risk factors for achalasia, but their contribution to disease pathogenesis is unknown. Nitric oxide is involved both in immune function and inhibitory neurotransmission.
OBJECTIVE: The objective of this article is to assess the association and the functional relevance of the CCTTT-inducible nitric oxide synthase (NOS2) gene promoter polymorphism in achalasia.
METHODS: Genomic DNA was isolated from 181 achalasia patients and 220 controls. Genotyping of the (CCTTT)n repeats was performed by PCR and capillary electrophoresis, and data analyzed by considering the frequency of the different alleles. HT29 cells were transfected with iNOS luciferase promoter-reporter plasmids containing different (CCTTT)n.
RESULTS: The alleles' distribution ranged from 7 to 18, with a peak frequency at 12 repeats. Analysis of the allele frequencies revealed that individuals carrying 10 and 13 CCTTT repeats were respectively less and more frequent in achalasia (OR 0.5, 95% CI 0.3-0.5 and OR 1.6, 95% CI 1-2.4, all p < 0.05). Long repeats were also significantly associated with an earlier onset of the disease (OR 1.69, 95% CI 1.13-2.53, p = 0.01). Transfection experiments revealed a similar allele-specific iNOS transcriptional activity.
CONCLUSION: The functional polymorphism (CCTTT) of NOS2 promoter is associated with achalasia, likely by an allele-specific modulation of nitric oxide production.

Entities:  

Keywords:  (CCTTT)n pentanucleotide; Idiopathic achalasia; genetic polymorphism; iNOS; nitric oxide

Year:  2016        PMID: 28344787      PMCID: PMC5349359          DOI: 10.1177/2050640616648870

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  49 in total

1.  Suggested association of NOS2A polymorphism in idiopathic achalasia: no evidence in a large case-control study.

Authors:  Ana González Vigo; Alfonso Martínez; Emilio G de la Concha; Elena Urcelay; Antonio Ruiz de León
Journal:  Am J Gastroenterol       Date:  2009-03-31       Impact factor: 10.864

Review 2.  Nitric oxide synthase in innate and adaptive immunity: an update.

Authors:  Christian Bogdan
Journal:  Trends Immunol       Date:  2015-02-13       Impact factor: 16.687

3.  Association between idiopathic achalasia and IL23R gene.

Authors:  A R de León; J P de la Serna; J L Santiago; C Sevilla; M Fernández-Arquero; E G de la Concha; C Nuñez; E Urcelay; A G Vigo
Journal:  Neurogastroenterol Motil       Date:  2010-03-31       Impact factor: 3.598

4.  HLA and enteric antineuronal antibodies in patients with achalasia.

Authors:  A Latiano; R De Giorgio; U Volta; O Palmieri; C Zagaria; V Stanghellini; G Barbara; A Mangia; A Andriulli; R Corinaldesi; V Annese
Journal:  Neurogastroenterol Motil       Date:  2006-07       Impact factor: 3.598

Review 5.  Etiology and pathogenesis of achalasia: the current understanding.

Authors:  Woosuk Park; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

Review 6.  Achalasia: will genetic studies provide insights?

Authors:  Henning R Gockel; Johannes Schumacher; Ines Gockel; Hauke Lang; Thomas Haaf; Markus M Nöthen
Journal:  Hum Genet       Date:  2010-08-11       Impact factor: 4.132

7.  Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 gene.

Authors:  Valentina Coia; Simone Jüliger; Benjamin Mordmüller; Andrea Kreidenweis; Anna-Lena Stroh; Claudia Ortega; Alessandro Vindigni; Jörn Dengjel; Dmitry V Lukyanov; Giovanni Destro-Bisol; Anton Fedorov; Olga I Podgornaya; Jürgen F J Kun
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

8.  Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.

Authors:  M A Gonzalez-Gay; J Llorca; E Sanchez; M A Lopez-Nevot; M M Amoli; C Garcia-Porrua; W E R Ollier; J Martin
Journal:  Rheumatology (Oxford)       Date:  2004-06-29       Impact factor: 7.580

9.  Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene.

Authors:  F Paladini; E Cocco; I Cascino; F Belfiore; D Badiali; L Piretta; F Alghisi; F Anzini; M T Fiorillo; E Corazziari; R Sorrentino
Journal:  Neurogastroenterol Motil       Date:  2009-02-27       Impact factor: 3.598

10.  Achalasia Is Associated With eNOS4a4a, iNOS22GA, and nNOS29TT Genotypes: A Case-control Study.

Authors:  Rajan Singh; Uday C Ghoshal; Asha Misra; Balraj Mittal
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

View more
  6 in total

1.  Inducible nitric oxide synthase gene polymorphisms are associated with a risk of nephritis in Henoch-Schönlein purpura children.

Authors:  Jue Jiang; Wuqiong Duan; Xu Shang; Hua Wang; Ya Gao; Peijun Tian; Qi Zhou
Journal:  Eur J Pediatr       Date:  2017-06-08       Impact factor: 3.183

2.  First genotype-phenotype study reveals HLA-DQβ1 insertion heterogeneity in high-resolution manometry achalasia subtypes.

Authors:  Zuzana Vackova; Stefan Niebisch; Tania Triantafyllou; Jessica Becker; Timo Hess; Nicole Kreuser; Stavroula Kanoni; Panos Deloukas; Vitalia Schüller; Sophie Km Heinrichs; René Thieme; Markus M Nöthen; Michael Knapp; Julius Spicak; Ines Gockel; Johannes Schumacher; Dimitris Theodorou; Jan Martinek
Journal:  United European Gastroenterol J       Date:  2018-10-03       Impact factor: 4.623

3.  An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia.

Authors:  Janette Furuzawa-Carballeda; Joaquín Zuñiga; Diana I Hernández-Zaragoza; Rodrigo Barquera; Eduardo Marques-García; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Gustavo Ramírez; Nora E Regino; Ramón Espinosa-Soto; Edmond J Yunis; Fernanda Romero-Hernández; Daniel Azamar-Llamas; Enrique Coss-Adame; Miguel A Valdovinos; Samuel Torres-Landa; Axel Palacios-Ramírez; Blanca Breña; Edgar Alejandro-Medrano; Axel Hernández-Ávila; Julio Granados; Gonzalo Torres-Villalobos
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 4.  Achalasia: Insights into Diagnostic and Therapeutic Advances for an Ancient Disease.

Authors:  Amir Mari; Kalp Patel; Mahmud Mahamid; Tawfik Khoury; Marcella Pesce
Journal:  Rambam Maimonides Med J       Date:  2019-01-28

5.  Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.

Authors:  Elena Cesaro; Andrea Patrizia Falanga; Rosa Catapano; Francesca Greco; Simona Romano; Nicola Borbone; Arianna Pastore; Maria Marzano; Federico Chiurazzi; Stefano D'Errico; Gennaro Piccialli; Giorgia Oliviero; Paola Costanzo; Michela Grosso
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

6.  Antioxidant and Anti-Inflammatory Activity of Coffee Brew Evaluated after Simulated Gastrointestinal Digestion.

Authors:  Luigi Castaldo; Marianna Toriello; Raffaele Sessa; Luana Izzo; Sonia Lombardi; Alfonso Narváez; Alberto Ritieni; Michela Grosso
Journal:  Nutrients       Date:  2021-12-05       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.